| Literature DB >> 33149446 |
Inderjit M Gowdar1, Sulaiman A Aldamigh2, Abdulrahman M Alnafisah2, Mohammed S Wabran2, Abdullah S Althwaini2, Tamim A Alothman2.
Abstract
BACKGROUND: To gain patient compliance, pediatric medication preparations are made palatable by adding sugars such as sucrose, glucose, or fructose. These readily fermentable carbohydrates can significantly increase dental caries potential in the young and chronically sick children.Entities:
Keywords: Acidic pH; acidogenic potential; hidden sugars; pediatric liquid medicaments
Year: 2020 PMID: 33149446 PMCID: PMC7595467 DOI: 10.4103/jpbs.JPBS_46_20
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
List of syrups (analgesics, antibiotics, and antitussives), the manufacturing company, and the active ingredient
| Category | Syrups | Manufacturers | Active ingredient |
|---|---|---|---|
| Analgesics | Fevadol – SF | SPIMACO, AL-Qassim Pharmaceutical Plant, Saudi Arabia | Paracetamol (120 mg/5 mL) |
| Sapofen Junior | SPIMACO, AL-Qassim Pharmaceutical Plant, Saudi Arabia | Ibuprofen (100 mg/5 mL) | |
| Nurofen | Reckitt Benckiser Healthcare International Limited, Hull, UK | Ibuprofen (100 mg/5 mL) | |
| Antibiotics | Megamox 312 | Jazeera Pharmaceutical Industries P O BOX 106229 Riyadh 11666, Saudi Arabia | Amoxicillin 250 mg and clavulanic acid (as potassium) 62.5 mg |
| Cefproz 250 | MEDPHARMA, UAE | Anhydrous cefprozil 250 mg | |
| Azomycin | Julphar, Gulf Pharmaceutical Industries, Ras Al Khaimah, UAE | Azithromycin 200 mg | |
| Antitussives | Amydramine | Julphar, Gulf Pharmaceutical Industries, Ras Al Khaimah, UAE. | Diphenhydramine HCL, sodium citrate, and menthol |
| Histop | SPIMACO, AL-Qassim Pharmaceutical Plant, Saudi Arabia | Chlorpheniramine maleate syrup (2 mg/5 mL) | |
| Lorinase | SPIMACO, AL-Qassim Pharmaceutical Plant, Saudi Arabia | Loratadine and pseudoephedrine sulfate |
Endogenous pH of the studied syrups
| Syrups | Mean | SD | ||
|---|---|---|---|---|
| Fevadol – SF | 4.96 | 0.15 | 493.23 | 0.000*** |
| Sapofen Junior | 5.26 | 0.11 | ||
| Nurofen | 4.46 | 0.05 | ||
| Megamox 312 | 4.53 | 0.11 | ||
| Cefproz 250 | 4.73 | 0.05 | ||
| Azomycin | 9.16 | 0.25 | ||
| Amydramine | 5.10 | 0.10 | ||
| Histop | 3.76 | 0.05 | ||
| Lorinase | 3.16 | 0.15 |
SD = standard deviation
P < 0.05
*** Highly significant
Multiple comparisons using Tukey honestly significant difference
| Syrup | Compared with | Mean difference (I–J) | Sig. |
|---|---|---|---|
| Fevadol – SF | Sapofen Junior | –0.30 | 0.187 |
| Nurofen | 0.50* | 0.005 | |
| Megamox 312 | 0.43* | 0.018 | |
| Cefproz 250 | 0.23 | 0.464 | |
| Azomycin | –4.20* | 0.000 | |
| Amydramine | –0.13 | 0.937 | |
| Histop | 1.20* | 0.000 | |
| Lorinase | 1.80* | 0.000 | |
| Sapofen Junior | Nurofen | 0.80* | 0.000 |
| Megamox 312 | 0.73* | 0.000 | |
| Cefproz 250 | 0.53333* | 0.003 | |
| Azomycin | –3.00* | 0.000 | |
| Amydramine | 0.16 | 0.820 | |
| Histop | 1.50* | 0.000 | |
| Lorinase | 2.10* | 0.000 | |
| Nurofen | Megamox 312 | –0.06 | 0.999 |
| Cefproz 250 | –0.26 | 0.305 | |
| Azomycin | –4.70* | 0.000 | |
| Amydramine | –0.63* | 0.000 | |
| Histop | 0.70* | 0.000 | |
| Lorinase | 1.30* | 0.000 | |
| Megamox 312 | Cefproz 250 | –0.20 | 0.648 |
| Azomycin | –4.63* | 0.000 | |
| Amydramine | –0.56* | 0.001 | |
| Histop | 0.76* | 0.000 | |
| Lorinase | 1.36* | 0.000 | |
| Cefproz 250 | Azomycin | –4.43* | 0.000 |
| Amydramine | –0.36 | 0.061 | |
| Histop | 0.96* | 0.000 | |
| Lorinase | 1.56* | 0.000 | |
| Azomycin | Amydramine | 4.06* | 0.000 |
| Histop | 5.40* | 0.000 | |
| Lorinase | 6.00* | 0.000 | |
| Amydramine | Histop | 1.33* | 0.000 |
| Lorinase | 1.93* | 0.000 | |
| Histop | Lorinase | 0.60* | 0.001 |
*The mean difference is significant at the 0.05 level